These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16924468)

  • 21. The natural history of gastro-esophageal reflux disease: a comprehensive review.
    Savarino E; de Bortoli N; De Cassan C; Della Coletta M; Bartolo O; Furnari M; Ottonello A; Marabotto E; Bodini G; Savarino V
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27862680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
    Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
    Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern.
    Bresadola V; Adani GL; Londero F; Leo CA; Cherchi V; Lorenzin D; Rossetto A; Vit G; Baccarani U; Terrosu G; Anna DD
    World J Gastrointest Pathophysiol; 2011 Jun; 2(3):42-8. PubMed ID: 21860835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease.
    Kanazawa Y; Isomoto H; Wen CY; Wang AP; Saenko VA; Ohtsuru A; Takeshima F; Omagari K; Mizuta Y; Murata I; Yamashita S; Kohno S
    World J Gastroenterol; 2003 Dec; 9(12):2801-4. PubMed ID: 14669337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acid-suppressive strategy against gastroesophageal reflux diseases and non-erosive reflux diseases: the alternative of proton- pump inhibitors or H2 receptor antagonists].
    Ishino Y; Sugano K
    Nihon Rinsho; 2007 May; 65(5):891-4. PubMed ID: 17511229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heartburn sensation in nonerosive reflux disease: pattern of superficial sensory nerves expressing TRPV1 and epithelial cells expressing ASIC3 receptors.
    Ustaoglu A; Sawada A; Lee C; Lei WY; Chen CL; Hackett R; Sifrim D; Peiris M; Woodland P
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G804-G815. PubMed ID: 33655767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study.
    Rantanen TK; Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Am J Gastroenterol; 2006 Feb; 101(2):222-8. PubMed ID: 16454822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus.
    Hartono JL; Qua CS; Goh KL
    Dig Dis Sci; 2011 Jan; 56(1):90-6. PubMed ID: 20467897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
    Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
    Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between baseline impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease.
    Borrelli O; Salvatore S; Mancini V; Ribolsi M; Gentile M; Bizzarri B; Cicala M; Lindley KJ; De'angelis GL
    Neurogastroenterol Motil; 2012 Sep; 24(9):828-e394. PubMed ID: 22680230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Proteinase-activated Receptor-2 in the Esophageal Mucosa of Gastroesophageal Reflux Disease Patients: A Histomorphologic and Immunohistochemical Study.
    Abd El-Rehim DM; Fath El-Bab HK; Kamal EM
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):646-52. PubMed ID: 25265427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
    Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reflux disease and Barrett's oesophagus - are there gender-specific differences?].
    Endlicher E; Gelbmann CM; Messmann H
    Z Gastroenterol; 2009 Oct; 47(10):1065-8. PubMed ID: 19809958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
    Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
    Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and natural history of gastroesophageal reflux disease.
    Savarino E; Marabotto E; Bodini G; Pellegatta G; Coppo C; Giambruno E; Brunacci M; Zentilin P; Savarino V
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):175-183. PubMed ID: 28215067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
    Malfertheiner P; Nocon M; Vieth M; Stolte M; Jaspersen D; Koelz HR; Labenz J; Leodolter A; Lind T; Richter K; Willich SN
    Aliment Pharmacol Ther; 2012 Jan; 35(1):154-64. PubMed ID: 22070159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study on the light microscopic measurement of intercellular space of squamous epithelium in lower-esophagus to diagnose gastroesophageal reflux disease].
    Cui RL; Zhou LY; Lin SR; Xue Y
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):208-12. PubMed ID: 19576088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.